[HTML] springer.com

[HTML][HTML] Casirivimab/imdevimab: first approval

ED Deeks - Drugs, 2021 - Springer
Abstract Casirivimab/imdevimab (Ronapreve™; REGEN-COV™) is a co-packaged
combination of two neutralizing immunoglobulin gamma 1 (IgG1) human monoclonal …
被引用次数：81 相关文章

Casirivimab/Imdevimab: First Approval

ED Deeks - Drugs, 2021 - pubmed.ncbi.nlm.nih.gov
Casirivimab/imdevimab (Ronapreve™; REGEN-COV™) is a co-packaged combination of
two neutralizing immunoglobulin gamma 1 (IgG1) human monoclonal antibodies …

Casirivimab/Imdevimab: First Approval

ED Deeks - Drugs, 2021 - search.proquest.com
Abstract Casirivimab/imdevimab (Ronapreve™; REGEN-COV™) is a co-packaged
combination of two neutralizing immunoglobulin gamma 1 (IgG1) human monoclonal …
[HTML] nih.gov

[HTML][HTML] Casirivimab/Imdevimab: First Approval

ED Deeks - Drugs, 2021 - ncbi.nlm.nih.gov
Abstract Casirivimab/imdevimab (Ronapreve™; REGEN-COV™) is a co-packaged
combination of two neutralizing immunoglobulin gamma 1 (IgG1) human monoclonal …

Casirivimab/Imdevimab: First Approval.

ED Deeks - Drugs, 2021 - search.ebscohost.com
Abstract Casirivimab/imdevimab (Ronapreve™; REGEN-COV™) is a co-packaged
combination of two neutralizing immunoglobulin gamma 1 (IgG1) human monoclonal …

Casirivimab/Imdevimab: First Approval.

ED Deeks - Drugs, 2021 - europepmc.org
Abstract Casirivimab/imdevimab (Ronapreve™; REGEN-COV™) is a co-packaged
combination of two neutralizing immunoglobulin gamma 1 (IgG1) human monoclonal …

[引用][C] Casirivimab/Imdevimab: First Approval

ED Deeks - Drugs, 2021 - cir.nii.ac.jp